News
-
Media Release: Discovery makes the invisible visibleBio21's Prof Eric Hanssen was part of La Trobe collaboration that discovered a new way to analyse microscopic cells, tissues and other transparent specimens, through the improvement of the phase contrast microscopy technique.
-
Bio21 ARC LIEF Grant SuccessBio21 teams have been successful with four University of Melbourne-led grants and one with the University of Wollongong.
-
What a great idea! Bio21 Researchers receive NHMRC Ideas fundingBio21's Hamish McWilliam, Kristin Brown, Justine Mintern, Isabelle Rouiller and Spencer Williams are the recipients of NHMRC Ideas grants commencing in 2021.
-
Bio21's Professor Sally Gras elected to the Australian Academy of Academy of Technology and EngineeringProfessor Sally Gras, group leader in the Department of Chemical Engineering at Bio21 and our Associate Director, Engagement is one of 25 new Fellows elected to the Academy of Technology and Engineering (ATSE).
-
Bio21 Members Funded for DiscoveryBio21 researchers, Spencer Williams, Paul Gooley, Elizabeth Hinde, Marc Sani and Ary Hoffmann are recipients of ARC Discovery and Linkage grants.
-
Pursuit: New drug target for sugar-coated virusesProfessor Gideon Davies, University of York and Bio21's Professor Spencer Williams and researchers from the Universities of Warwick and Oxford have shed light on how encapsulated viruses like SARS-CoV-2 hijack the protein manufacturing and distribution pathways in the cell, as well as a drug target to stop them in their tracks.
-
Andrew Wilks, elected as a Fellow to the Australian Academy of Health and Medical SciencesAndrew Wilks is CEO of SYNthesis Group, headquartered at Bio21 since 2018
-
Prof Gavin Reid, included on The Analytical Scientist Power List 2020Prof Gavin Reid, included on The Analytical Scientist Power List 2020
-
NHMRC funds Bio21 researchProfessors Eric Reynolds and Paul Gooley have received NHMRC funding to investigate tooth repair and Chronic Fatigue Syndrome.
-
Media release: Novel drug in development to inhibit acute inflammationTeams led by Bio21's Prof Michael Parker and Prof Karlheinz Peter, Baker in the new Department of Cardiometabolic Health are developing a new anti-inflammatory drug.
